Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase complex recruitment refers to the process by which E3 ubiquitin ligases, often as part of multi-protein complexes, are brought into proximity with specific substrate proteins. This recruitment is a critical step in the ubiquitination pathway—a post-translational modification system that tags proteins with ubiquitin for various cellular fates, most notably proteasomal degradation. The specificity of substrate recognition and recruitment is primarily determined by the E3 ligase or its associated adaptor/substrate receptor subunits. Ubiquitination regulates protein stability, localization, interactions, and activity—affecting nearly all aspects of eukaryotic cell biology including cell cycle progression, signal transduction, DNA repair, and immune responses. Dysregulation leads to diseases such as cancer. Therapeutic strategies such as PROTACs exploit this mechanism.
Recruitment of E3 ligase complex to target protein, leading to ubiquitination and subsequent degradation or altered function.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 Ubiquitin-Protein Ligase Complex Recruitment (E3 Ligase Complex Recruitment).